Quantinuum Inc. (QNT) — IPO Dossier

Quantinuum prices on Nasdaq at $60 — above its $53–$55 range — as a 100% primary, roughly $1.68 billion raise, and what public investors actually buy is about 12.6% of the economics of a Honeywell-anchored quantum-computing company through an Up-C structure with a Tax Receivable Agreement. The company keeps the proceeds; the structure keeps most of the upside with the pre-IPO holders.

Demand read

QNT scores BDI 76 — ACTIVE — on four inputs: the Pricing Signal, Underwriter Quality, Sector Momentum, and Market Regime. The strongest input is the Pricing Signal: Quantinuum priced at $60, above its $53–$55 marketed range, which the engine reads as a top-tier demand outcome — the book was oversubscribed enough that underwriters pushed the clearing price through the top of the range. That is the constructive half of the read, reinforced by a Tier-1 syndicate led by J.P. Morgan and Morgan Stanley across thirteen firms and a healthy technology-sector momentum read. The cautionary half is the macro regime at the time of pricing — an elevated VIX near 21.5 and a soft tape (the broad market off about 2.6% on the day) — which holds the score back from the blowout tier and is the main reason a deal that priced above its range still lands at 76 rather than the high 80s. ACTIVE signals solid, healthy institutional demand for a high-profile name raising about $1.68B, without the saturation of a true blowout. One caveat on interpretation: a strong demand read is not a verdict on the underlying economics — the Up-C structure and Tax Receivable Agreement route most of the upside to pre-IPO holders, which BDI does not weigh. BDI measures demand intensity at pricing, not whether the stock is a good investment, and is not a buy or sell signal.

The Bellipo take

This is a landmark quantum-computing IPO with a structure that deserves as much attention as the technology. Quantinuum is a vertically integrated trapped-ion quantum computer maker, formed in 2021 by combining Honeywell Quantum Solutions and Cambridge Quantum, with roughly 700 employees and its Helios system. The offering is 100% primary — no selling stockholders — and sized large: about $1.68B gross to the company at the $60 price, which priced above the $53–$55 marketed range. That is real capital into the business, and the above-range pricing is a genuine demand signal — the constructive half. The caution is twofold and structural. First, the economics of what a public buyer receives: this is an Up-C, and Quantinuum Inc.'s only asset is about 12.6% of Quantinuum Holdings; the Continuing Common Unitholders — principally Honeywell — hold about 87.4%, and Honeywell carries about 49.1% of combined voting power post-offering. A Tax Receivable Agreement routes 85% of the company's realized cash tax savings to those pre-IPO holders, not to public shareholders. Second, the financial profile of an early-stage platform: FY2025 net revenue was $30.9M against a $192.6M net loss, and bookings were $79.3M. Q1 2026 revenue of $5.2M looks alarming against $19.1M a year earlier, but the prior quarter was inflated by a one-time $16.5M upfront sales-type lease recognition, and the Q1 2026 loss widened mainly on a $64.2M non-cash warrant fair-value charge rather than operations. Notably, the filing discloses no going-concern doubt — $677.0M of cash backs a stated runway of more than twelve months. Read the Up-C economics and the TRA as carefully as the qubits.